Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bioxcel is a leading US biotechnology company specializing in the development of innovative AI-driven therapies. Through cutting-edge pharmacology, Bioxcel optimizes targeted treatment approaches in neuroscience and immunology to provide more precise patient care.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bioxcel is scheduled to report its next quarterly earnings on 11/18/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bioxcel last reported quarterly earnings on 5/15/2026 (Q1 2026). Earnings per share (EPS) came in at -0.54 USD.
Across its last 3 earnings reports, Bioxcel stock moved by ±4.8% on average the following day. The largest reaction was -8% on 03/27/2026; 1 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.